7 Recruiting Irritable Bowel Syndrome Phase 2 Clinical Trials
Active phase 2 studies for irritable bowel syndrome enrolling across the USA. Verify eligibility and contact site coordinators.
All Irritable Bowel Syndrome studiesPhase 2 Studies for Irritable Bowel Syndrome
🔵 Active, Not Recruiting Phase2
Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
📍 GSK Investigational Site — Anniston, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
📍 Del Sol Research Management - Mesa — Mesa, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
📍 Del Sol Research Management - Mesa — Mesa, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2
Psyllium in Pediatric IBS
📍 Duke University — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
📍 HealthStar Research of Hot Springs PLLC /ID# 234609 — Hot Springs, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase2
Fecal Microbiota Transplantation for IBS
📍 Mayo Clinic in Minnesota — Rochester, Minnesota
View Study & Checklist ➔